Search

Tinnitus and music

Marc Fagelson discusses how not just hearing loss, but tinnitus and hyperacusis and impairments to an individual’s ability to process music can adversely affect one’s quality of life, as well as their overall interactions from a societal and personal perspective....

Adult speech testing in the UK

What do hearing healthcare providers see as the benefits and barriers to delivering speech testing? This article explores the latest research. Why speech testing? Speech tests have been used across ENT and audiology practice to measure an individual’s speech recognition...

Big data and the future of cochlear implant aftercare

With a million people using cochlear implants worldwide, the time is right for us to harness this vast data for patient benefit. Every day, cochlear implant (CI) processors quietly collect data: how long they’re worn, how often users switch programs...

Getting to grips with acoustic trauma

Our understanding of hearing loss caused by noise exposure to those in the armed forces is growing in interest and understanding. Research at a cellular level is essential to increase our understanding so that we can better diagnose, manage and...

The changing landscape for hearing loss therapeutics: novel advances of gene and cell therapies

Recent years have seen advances in hearing loss therapeutics, with novel treatments trialled in humans, and others nearing promising first-in-kind clinical trials. First successful clinical trials for a specific form of genetic hearing loss Very exciting news has emerged in...

In conversation with Prof Helge Rask-Andersen: on cell regeneration and treatment of human deafness

Helge Rask-Andersen, head of the inner ear research laboratory at the University of Uppsala in Sweden, has many achievements to his name. He was made an Honorary Member of ENT UK earlier this year. Gerry O’Donoghue caught up with him...

Maxillofacial and neck surgery in Iraq and Afghanistan

Introduction Over the past 150 years, military personnel wounded in action had a survival rate of approximately 80% [1]. During the current conflicts in Iraq and Afghanistan, those servicemen wounded in action have a 90.4% survival rate [2]. During the...

NHS collaboration and partnership with the pharmaceutical and medical devices industries

Historically the relationship between industry and the NHS has been a cautious one. Both sides have typically worked with only partially disclosed agendas, under a pervading fear of finding themselves on the wrong end of a win-lose negotiation. Things have...

Thyroid cancer – the last decade

Professor Ashok Shaha describes the evolution in the treatment of thyroid cancer that he has witnessed over the last decade and the invaluable progress made by himself and others, from their contributions to staging systems and guidelines. Nuances and paradigm...

The future of inner ear drug delivery

The techniques for delivering drugs to the inner ear system are evolving. Jeffrey Harris considers the myths, the facts and the potential for drug delivery innovations and how they can improve tomorrow’s hearing outcomes. The inner ear’s delicate membranous structure,...